The chip giant still faces concerns about security flaws in its chips, but strong results overshadow worries.

Spinoffs and asset sales may benefit shareholders more than chasing growth in a frenzied health-care deals market.

Activist investors who broke up the $15 billion Clariant-Huntsman merger promised a long-term approach to creating value. Three months later, they’ve

As junk-bond issuance has surged in Asia, the quality of investor-protecting bond covenants has plunged.

General Electric’s new transparency is welcome, but a focus on cash shows that the company is probably no bargain even after its swoon.

Rates for home loans jumped as bonds sold off.